BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16224255)

  • 1. Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays.
    Assassi S; Tan FK
    Curr Opin Rheumatol; 2005 Nov; 17(6):761-7. PubMed ID: 16224255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel targets in scleroderma: update on population studies, cDNA arrays, SNP analysis, and mutations.
    Ahmed SS; Tan FK
    Curr Opin Rheumatol; 2003 Nov; 15(6):766-71. PubMed ID: 14569208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of scleroderma (systemic sclerosis).
    Agarwal SK; Reveille JD
    Curr Opin Rheumatol; 2010 Mar; 22(2):133-8. PubMed ID: 20090527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of scleroderma.
    Martin J; Fonseca C
    Curr Rheumatol Rep; 2011 Feb; 13(1):13-20. PubMed ID: 20960081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sclerosis: the susceptible host (genetics and environment).
    Tan FK
    Rheum Dis Clin North Am; 2003 May; 29(2):211-37. PubMed ID: 12841292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of scleroderma: looking into the postgenomic era.
    Mayes MD
    Curr Opin Rheumatol; 2012 Nov; 24(6):677-84. PubMed ID: 23026857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and proteomics in scleroderma.
    Feghali-Bostwick CA
    Curr Rheumatol Rep; 2005 Apr; 7(2):129-34. PubMed ID: 15760592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the genetics of systemic sclerosis: toward biological and clinical significance.
    Korman BD; Criswell LA
    Curr Rheumatol Rep; 2015 Mar; 17(3):21. PubMed ID: 25777745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of systemic sclerosis: an update.
    Romano E; Manetti M; Guiducci S; Ceccarelli C; Allanore Y; Matucci-Cerinic M
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S75-86. PubMed ID: 21586222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Basis for Dysregulated Activation of NKX2-5 in the Vascular Remodeling of Systemic Sclerosis.
    Dritsoula A; Papaioannou I; Guerra SG; Fonseca C; Martin J; Herrick AL; Abraham DJ; Denton CP; Ponticos M
    Arthritis Rheumatol; 2018 Jun; 70(6):920-931. PubMed ID: 29342503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of interleukin 1α promoter polymorphism (-889C/T) with susceptibility to systemic sclerosis.
    Peng WJ; Wang BX; Pan HF; Wang J
    J Rheumatol; 2012 Aug; 39(8):1755; author reply 1755. PubMed ID: 22859533
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between a CTGF gene polymorphism and systemic sclerosis in a French population.
    Granel B; Argiro L; Hachulla E; Fajardy I; Weiller PJ; Durand JM; Frances Y; Dombey AM; Marquet S; Lesavre N; Disdier P; Bernard F; Hatron PY; Chevillard C
    J Rheumatol; 2010 Feb; 37(2):351-8. PubMed ID: 20032097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of STAT4 polymorphism with systemic sclerosis in a Japanese population.
    Tsuchiya N; Kawasaki A; Hasegawa M; Fujimoto M; Takehara K; Kawaguchi Y; Kawamoto M; Hara M; Sato S
    Ann Rheum Dis; 2009 Aug; 68(8):1375-6. PubMed ID: 19605749
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic susceptibility to systemic sclerosis from clinical aspect to genetic factor analyses.
    Granel B; Bernard F; Chevillard C
    Eur J Intern Med; 2009 May; 20(3):242-52. PubMed ID: 19393491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma.
    Zhou X; Tan FK; Reveille JD; Wallis D; Milewicz DM; Ahn C; Wang A; Arnett FC
    Arthritis Rheum; 2002 Nov; 46(11):2990-9. PubMed ID: 12428242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on: An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis.
    Zhang Y; Pointon JJ; Wordsworth BP
    Rheumatology (Oxford); 2008 Apr; 47(4):556-7; author reply 557. PubMed ID: 18084000
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenetics of systemic sclerosis.
    Dieudé P; Boileau C; Allanore Y
    Autoimmun Rev; 2011 Mar; 10(5):282-90. PubMed ID: 20863905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis.
    Hutyrová B; Lukác J; Bosák V; Buc M; du Bois R; Petrek M
    J Rheumatol; 2004 Jan; 31(1):81-4. PubMed ID: 14705223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IL-33 gene is related to increased susceptibility to systemic sclerosis.
    Koca SS; Pehlivan Y; Kara M; Alibaz-Oner F; Oztuzcu S; Yilmaz N; Cetin GY; Kisacik B; Ozgen M; Pamuk ON; Direskeneli H; Sayarlioglu M; Onat AM
    Rheumatol Int; 2016 Apr; 36(4):579-84. PubMed ID: 26743213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics: The Future Direction in Systemic Sclerosis.
    Walczyk M; Paradowska-Gorycka A; Olesinska M
    Scand J Immunol; 2017 Dec; 86(6):427-435. PubMed ID: 28930377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.